All

Meet ASPIRE: Galderma Rolls Out New Customer Loyalty Program

Galderma is rolling out a new loyalty program for both doctors and patients.

All

Galderma Opens New Headquarters in Miami to Support US and Latin American Operations

The facility features a dedicated training space for healthcare professionals and supports the company’s long-term investment in the dermatology market.

All

FDA Clears NOUVAG’s LipoSurg ARTIST System for Power-Assisted Liposuction

The device combines tumescent local anesthesia infiltration, power-assisted tissue removal, and aspiration into a single platform.

Nemolizumab Shows Early Relief of Itch and Sleep Disruption in Chronic Skin Conditions

by Alyx Arnett | Dec 24, 2025 | Dermatology | 0

Post-hoc analyses of phase III trials suggest some patients experienced improvements within days of treatment for atopic dermatitis and prurigo nodularis.

Sculptra Gains EU Certification for New Body Indications

by Alyx Arnett | Dec 5, 2025 | Body Makeover | 0

The regenerative biostimulator is now certified for use in four new body areas.

FDA Approves Restylane Lyft for Chin Augmentation

by Alyx Arnett | Nov 5, 2025 | Injectibles | 0

Pivotal trial data showed sustained improvement in chin projection and high patient and investigator satisfaction through 12 months.

Integrating Financing and Rewards to Build Patient Loyalty

by Alison Werner | Oct 14, 2025 | Patient Finance | 0

Two physicians discuss how integrated patient financing and loyalty programs are transforming access, affordability, and retention in aesthetic practices.

New Studies Highlight Injectable Advances in Chin Augmentation, Weight Loss–Related Volume Loss, and Neuromodulators

by Alyx Arnett | Sep 24, 2025 | Injectibles | 0

Data on a hyaluronic acid filler for chin shaping, a biostimulator for medication-driven weight loss effects, and a liquid neuromodulator will be presented at the upcoming AMWC Dubai.

Galderma Reports Positive Results for Facial Volume Loss Tied to Medication-Driven Weight Loss

by Alyx Arnett | Jul 18, 2025 | Injectibles | 0

The phase IV trial evaluated outcomes of Sculptra plus Restylane Lyft or Contour in patients with facial volume loss due to weight loss medications.

AAD Issues Strong Recommendations for Four Therapies in Updated Atopic Dermatitis Guidelines

by Alyx Arnett | Jul 11, 2025 | Eczema | 0

The American Academy of Dermatology issued four strong evidence-based recommendations for the treatment of atopic dermatitis in adults in its 2025 focused update.

Galderma Launches ‘Scratch Resistance’ Campaign for Atopic Dermatitis Treatment

by Alyx Arnett | Apr 23, 2025 | Eczema | 0

The broadcast and digital campaign aims to spotlight the emotional burden of eczema-related itch and promote Galderma’s Nemluvio.

Galderma Launches Updated Alastin Restorative Skin Complex with New Ingredients

by Alyx Arnett | Apr 18, 2025 | Cosmetics & Skin Care | 0

Alastin’s enhanced serum includes a proprietary peptide and novel fat-stimulating ingredient for collagen and volume support.

Galderma Restylane Eyelight HA Filler Receives FDA Approval

by Alison Werner | Jun 5, 2023 | Anti-Aging, Injectibles | 0

Restylane Eyelight, an undereye hyaluronic acid (HA) dermal filler, is formulated with NASHA Technology for volume loss under the eyes.

Galderma Sponsors SCOPE Miami Beach 2022

by Steven Martinez | Nov 28, 2022 | Injectibles | 0

Galderma is sponsoring the SCOPE Miami Beach 2022 showcase for contemporary art, offering consultations and real-time treatments to visitors.

Galderma, NBCF to Launch Campaign Elevating Skin Stories of Breast Cancer Survivors

by Keri Stephens | Oct 3, 2022 | Breast Cancer, Company News | 0

Galderma is featuring the personal stories and treatment journeys of breast cancer survivors who received Galderma’s aesthetic portfolio of products in a campaign on their social channels during Breast Cancer Awareness Month in October.